Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Enochian Biosciences Inc (ENOB)

Enochian Biosciences Inc (ENOB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 353,906
  • Shares Outstanding, K 48,085
  • Annual Sales, $ 0 K
  • Annual Income, $ -11,420 K
  • 60-Month Beta 0.38
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.28
Trade ENOB with:

Options Overview Details

View History
  • Implied Volatility 109.36%
  • Historical Volatility 60.54%
  • IV Percentile 23%
  • IV Rank 8.37%
  • IV High 193.09% on 07/02/21
  • IV Low 101.70% on 08/05/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 98
  • Volume Avg (30-Day) 87
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 277
  • Open Int (30-Day) 223

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.35 +15.90%
on 08/25/21
8.08 -8.91%
on 09/07/21
+0.69 (+10.34%)
since 08/24/21
3-Month
4.42 +66.52%
on 07/19/21
8.08 -8.91%
on 09/07/21
+1.58 (+27.34%)
since 06/24/21
52-Week
2.60 +183.08%
on 11/27/20
12.99 -43.34%
on 06/14/21
+3.94 (+115.20%)
since 09/24/20

Most Recent Stories

More News
Enochian BioSciences to Present to Investors at the H.C. Wainwright 23rd Annual Investment Conference

Enochian BioSciences, a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that it will be making a company presentation to investors at the...

ENOB : 7.36 (+2.08%)
Distinguished Scientific and Public Health Leaders to Join Enochian BioSciences' Scientific Advisory Board for Potential Inhaled Treatment and Prevention of All COVID-19 and Influenza Variants

LOS ANGELES, Aug. 30, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) - Enochian BioSciences, a company focused on gene-modified cellular and immune therapies for infectious diseases and cancer, announced the...

ENOB : 7.36 (+2.08%)
Distinguished Scientific and Clinical Leader to Join Enochian BioSciences' Hepatitis B Cure Scientific Advisory Board

(NASDAQ: ENOB) - Enochian BioSciences, a company focused on gene modified cellular and immune therapies for infectious diseases and cancer, announced that the renowned Dr. Anna Suk-Fong Lok, MD, has joined...

ENOB : 7.36 (+2.08%)
Enochian BioSciences Names The Hon. Dr. Mark Dybul as Chief Executive Officer

Dr. Dybul's Deep and Prestigious Scientific Research Expertise Helps to Affirm Enochian BioSciences' Scientific Approach

ENOB : 7.36 (+2.08%)
Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential Cure for Hepatitis B Virus Infection

LOS ANGELES, July 12, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) - Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced...

ENOB : 7.36 (+2.08%)
Enochian BioSciences Announces Scientific Presentation of Elimination of HBV in Mice with No Evident Toxicity

LOS ANGELES, June 30, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) - Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced...

ENOB : 7.36 (+2.08%)
Enochian BioSciences Announces Acquisition of Exclusive License for Potential Pan-Coronavirus and Pan-Influenza Inhaled Treatment and Prevention Technology

Request for Pre-Investigator New Drug Meeting to Be Submitted to FDA in Near Term

ENOB : 7.36 (+2.08%)
Pioneering Research Institute In Los Angeles Moves One Step Closer To Finding A Cure For HIV

/PRNewswire/ -- (NASDAQ: ENOB) – A promising cure for HIV is moving one step closer to FDA approval. The novel approach to treating HIV in humans using cell therapy, developed by Dr. Serhat Gumrukcu...

ENOB : 7.36 (+2.08%)
Enochian BioSciences Announces $29 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

LOS ANGELES, June 14, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) -- Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today...

ENOB : 7.36 (+2.08%)
Thinking about buying stock in ContextLogic, BlackBerry, Enochian Biosciences, Novan, or Recon Technology?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for WISH, BB, ENOB, NOVN, and RCON.

ENOB : 7.36 (+2.08%)
NOVN : 8.14 (-3.78%)
WISH : 6.02 (-1.87%)
RCON : 2.71 (-2.87%)
BB : 10.38 (-2.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Enochian BioSciences Inc. engages in the research and development, manufacturing and clinical trials of pharmaceutical and biological products for the human treatment of HIV and cancer. The company's product pipeline consists of ENO-1001, ENO-2001, ENO-3001, ENO-1002, ENO-5001 and ENO-4001. Enochian...

See More

Key Turning Points

3rd Resistance Point 8.15
2nd Resistance Point 7.88
1st Resistance Point 7.62
Last Price 7.36
1st Support Level 7.08
2nd Support Level 6.81
3rd Support Level 6.55

See More

52-Week High 12.99
Fibonacci 61.8% 9.02
Fibonacci 50% 7.80
Last Price 7.36
Fibonacci 38.2% 6.57
52-Week Low 2.60

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar